![]() |
|||
| Research | Core Facilities | Patient Studies | Tech Transfer | Seminars | Intranet | Jobs | Search | Contact Us | Ways To Give HOME | |||
|
|
Hiding in Plain Sight OMRF researchers discover rogue immune cells in healthy adults
The new findings could be key to developing new ways to prevent and treat autoimmune diseases, conditions like rheumatoid arthritis, lupus and type I (juvenile) diabetes that, in total, affect up to 24 million Americans. Immune cells are the body’s police force, summoned to fight infections and viruses. In patients with autoimmune diseases, those immune cells go “rogue,” attacking not just foreign invaders but also the body’s own organs and systems. In a study published in the new issue of The Journal of Experimental Medicine, OMRF scientists found that in healthy adults, rogue immune cells account for 2.5 percent of immune cells. But unlike in those suffering from autoimmune disease, the rogue cells in healthy individuals appear to be inactive. “According to test we did, we found those immune cells were dormant, so they wouldn’t become active or dangerous,” said J. Andrew Duty, Ph.D., the lead author on the paper.
The dormant rogue immune cells don’t cause problems in healthy adults, but given the right stimulus in laboratory experiments, they become activated. Duty said the next step would likely be to find out why those immune cells are dormant and if there’s a signal that turns them off to keep them from being dangerous. “If we can discover how the body stops these cells from being turned on, it could offer new insight into how to prevent autoimmune disease,” said Duty. “And if we figure out how the body turns the rogue cells off, that could lead to new treatment strategies for diseases like lupus and rheumatoid arthritis.” OMRF (omrf.org) is an independent, nonprofit biomedical research institute dedicated to understanding and developing more effective treatments for human disease. Its scientists focus on such critical research areas as Alzheimer’s disease, cancer, lupus and cardiovascular disease. The study was funded by a grant from the National Institutes of Health.
About autoimmune disease:
|
|
|
|